Follow
Ioannis Kagiampakis
Ioannis Kagiampakis
MedImmune, Johns Hopkins University, National Cancer Institute - NIH, Texas A&M University
Verified email at medimmune.com
Title
Cited by
Cited by
Year
Sorghum bicolor’s Transcriptome Response to Dehydration, High Salinity and ABA
CD Buchanan, S Lim, RA Salzman, I Kagiampakis, DT Morishige, ...
Plant molecular biology 58, 699-720, 2005
3642005
Chronic cigarette smoke-induced epigenomic changes precede sensitization of bronchial epithelial cells to single-step transformation by KRAS mutations
M Vaz, SY Hwang, I Kagiampakis, J Phallen, A Patil, HM O'Hagan, ...
Cancer cell 32 (3), 360-376. e6, 2017
1792017
Triggering of RNA Interference with RNA–RNA, RNA–DNA, and DNA–RNA Nanoparticles
KA Afonin, M Viard, I Kagiampakis, CL Case, MA Dobrovolskaia, ...
ACS nano 9 (1), 251-259, 2015
1292015
DNA methylation patterns separate senescence from transformation potential and indicate cancer risk
W Xie, I Kagiampakis, L Pan, YW Zhang, L Murphy, Y Tao, X Kong, ...
Cancer cell 33 (2), 309-321. e5, 2018
1012018
Integrated genomic, epigenomic, and expression analyses of ovarian cancer cell lines
E Papp, D Hallberg, GE Konecny, DC Bruhm, V Adleff, M Noë, ...
Cell reports 25 (9), 2617-2633, 2018
892018
Targeting hexokinase 2 inhibition promotes radiosensitization in HPV16 E7-induced cervical cancer and suppresses tumor growth
Y Liu, T Murray-Stewart, RA Casero, I Kagiampakis, L Jin, J Zhang, ...
International journal of oncology 50 (6), 2011-2023, 2017
652017
Untitled
US Patent US2,011, 0
53*
Bolaamphiphiles as carriers for siRNA delivery: From chemical syntheses to practical applications
K Gupta, KA Afonin, M Viard, V Herrero, W Kasprzak, I Kagiampakis, ...
Therapeutic RNA Nanotechnology, 355-385, 2021
502021
The role of individual carbohydrate-binding sites in the function of the potent anti-HIV lectin griffithsin
J Xue, Y Gao, B Hoorelbeke, I Kagiampakis, B Zhao, B Demeler, ...
Molecular pharmaceutics 9 (9), 2613-2625, 2012
472012
The griffithsin dimer is required for high-potency inhibition of HIV-1: evidence for manipulation of the structure of gp120 as part of the griffithsin dimer mechanism
J Xue, B Hoorelbeke, I Kagiampakis, B Demeler, J Balzarini, PJ LiWang
Antimicrobial agents and chemotherapy 57 (8), 3976-3989, 2013
462013
A KDM5 inhibitor increases global H3K4 trimethylation occupancy and enhances the biological efficacy of 5-Aza-2′-deoxycytidine
BR Leadem, I Kagiampakis, C Wilson, TK Cheung, D Arnott, P Trojer, ...
Cancer Research 78 (5), 1127-1139, 2018
402018
Potent strategy to inhibit HIV-1 by binding both gp120 and gp41
I Kagiampakis, A Gharibi, MK Mankowski, BA Snyder, RG Ptak, K Alatas, ...
Antimicrobial agents and chemotherapy 55 (1), 264-275, 2011
382011
Structural and functional studies of the potent anti‐HIV chemokine variant P2‐RANTES
H Jin, I Kagiampakis, P Li, PJ LiWang
Proteins: Structure, Function, and Bioinformatics 78 (2), 295-308, 2010
252010
HIV-1 matrix trimerization-impaired mutants are rescued by matrix substitutions that enhance envelope glycoprotein incorporation
PR Tedbury, M Novikova, A Alfadhli, Y Hikichi, I Kagiampakis, ...
Journal of virology 94 (1), 10.1128/jvi. 01526-19, 2019
232019
Nickel-dependent oligomerization of the alpha subunit of acetyl-coenzyme a synthase/carbon monoxide dehydrogenase
X Tan, I Kagiampakis, IV Surovtsev, B Demeler, PA Lindahl
Biochemistry 46 (41), 11606-11613, 2007
142007
Detecting protein dissimilarities in multiple alignments using Bayesian variable selection
S Kim, J Tsai, I Kagiampakis, P LiWang, M Vannucci
Bioinformatics 23 (2), 245-246, 2007
42007
Conservation of unfavorable sequence motifs that contribute to the chemokine quaternary state
I Kagiampakis, H Jin, S Kim, M Vannucci, PJ LiWang, J Tsai
Biochemistry 47 (40), 10637-10648, 2008
32008
An information measure of the quality of protein secondary structure prediction
R Swanson, I Kagiampakis, JW Tsai
Journal of Computational Biology 15 (1), 65-79, 2008
32008
Triggering of RNA Interference with RNA–RNA, RNA–DNA, and DNA–RNA Nanoparticles
KA Afonin, M Viard, I Kagiampakis, CL Case, MA Dobrovolskaia, ...
Therapeutic RNA Nanotechnology, 681-705, 2021
12021
Improving the anti-HIV potency of different compounds through synergy and covalent linkage: Dimerization studies of CXCL8
I Kagiampakis
Texas A&M University, 2010
2010
The system can't perform the operation now. Try again later.
Articles 1–20